Senzime AB (STU:6YC) Total Tax Payable : €0.00 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Senzime AB Total Tax Payable?

Senzime AB's Total Tax Payable for the quarter that ended in Sep. 2024 was €0.00 Mil.

Senzime AB's annual Total Tax Payable increased from Dec. 2021 (€0.06 Mil) to Dec. 2022 (€0.09 Mil) and increased from Dec. 2022 (€0.09 Mil) to Dec. 2023 (€0.11 Mil).

Senzime AB Total Tax Payable Historical Data

The historical data trend for Senzime AB's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senzime AB Total Tax Payable Chart

Senzime AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

0.06

0.43

0.06

0.09

0.11

Senzime AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Tax Payable	Get a 7-Day Free Trial															-	0.11	-	-	-

Senzime AB Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Senzime AB Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Senzime AB's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Senzime AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (STU:6YC) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

SNZZF:USA SEZI:Sweden

Address

Ulls vag 41, Uppsala, SWE, 756 51

Website

https://www.senzime.com

Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its products include TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States of America which generates key revenue, Europe/Oceania, and Asia.

Senzime AB Headlines

No Headlines